We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.59 | 6.21% | 27.21 | 27.45 | 26.02 | 26.3295 | 97,521,966 | 00:59:15 |
Among the companies with shares expected to actively trade in Tuesday's session are Best Buy Co. (BBY), Burger King Worldwide Inc. (BKW) and DSW Inc. (DSW).
Best Buy posted a stronger-than-expected quarterly profit as the electronics retailer's cost-trimming and e-commerce initiatives started to pay off, though sales continued to decline with no immediate sign of a letup. Shares declined 4.2% to $30.66 premarket.
Burger King agreed to buy Canadian coffee-and-doughnut-chain Tim Hortons Inc. (THI, THI.T) for about $11 billion, confirming plans to move the iconic American brand north of the border under a tax inversion deal with the help of billionaire investor Warren Buffett. Burger King shares edged up 2% to $33.04 premarket.
DSW said fiscal second-quarter profit edged up 1.8%, with results outpacing market expectations as net sales and same-store sales increased across its segments. The discount shoe retailer also raised both ends of its full-year per-share earnings guidance by five cents. Shares surged 11% to $31.50 premarket.
Sanderson Farms Inc. (SAFM) said its fiscal third-quarter profit rose 12%, driven by higher sales and poultry product prices. The results, however, fell far short of analysts' expectations, sending shares down 5.9% to $89.56 premarket.
Trina Solar Ltd. (TSL) said it swung to a profit in the second quarter, but its solar-module shipments in the period fell just shy of expectations. Shares dropped 6.7% to $12.48 premarket.
Watch List:
Pfizer Inc. (PFE) and Merck & Co. (MRK) said they would collaborate on another study evaluating a potential lung-cancer treatment, the latest partnership of pharmaceutical companies looking to capitalize on the emergence of immunotherapy in fighting the disease.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions